About Rangsubbs Pharmaceuticals (India) Private Limited
Data last updated:
Rangsubbs Pharmaceuticals (India) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24302TG2017PTC119103. Its GSTIN is 36AAICR4831M1ZY (Telangana).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.39 Cr. It is led by directors Srinivas Rao Naga Boyalapalli (Managing Director) and Devarakonda Ravi Sankar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2018, the company reported a revenue of ₹6.34 Lakh. For the same year it recorded a net loss of ₹13.23 Lakh (net margin -208.6%) and EBITDA of -₹17.07 Lakh (EBITDA margin -269.3%).
The company has about 1 employee on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rangsubbs.com.
Company details
Contact details
Rangsubbs Pharmaceuticals (India) Private Limited's registered office is in Hyderabad, Telangana. Its website is rangsubbs.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressAparna Aura Apartments Flat No 906, Road No 79 Jubilee Hills, Hyderabad, Telangana, India – 500096
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rangsubbs Pharmaceuticals (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Rangsubbs Pharmaceuticals (India) Private Limited
FY 2018 filings availableRangsubbs Pharmaceuticals (India) Private Limited reported revenue of ₹6.34 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹6.34 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹17.07 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹13.23 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | -269.3% |
| Net Profit Margin | -208.6% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Rangsubbs Pharmaceuticals (India) Private Limited
Rangsubbs Pharmaceuticals (India) has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivas Rao Naga Boyalapalli | Managing Director | 24 Aug 2017 | 9 Years 2 Months | Current |
| Devarakonda Ravi Sankar Also directs: Indira Ravi Healthcare India Private Limited | Director | 16 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Rangsubbs Pharmaceuticals (India) Private Limited is audited by R MOHAN RAO & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R MOHAN RAO & CO | FY 2018 | 017827S |
Shareholding
The shareholding of Rangsubbs Pharmaceuticals (India) Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rangsubbs Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rangsubbs Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rangsubbs Pharmaceuticals (India) Private Limited has a workforce of 1 employees on its EPFO records as of Apr 2022, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2022-23 | 1 |
| FY 2021-22 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
GST
Rangsubbs Pharmaceuticals (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICR4831M1ZY | Telangana | Active | 16 Oct 2017 |
To see the full GST registrations and return filing status of Rangsubbs Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Rangsubbs Pharmaceuticals (India) Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Gangarapu Reddeppa Naidu ceased to be Additional Director on 26 Aug 2021.
Frequently asked questions
Rangsubbs Pharmaceuticals (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 2017 (9+ years old) and is registered under CIN U24302TG2017PTC119103.
Rangsubbs Pharmaceuticals (India) has 2 current directors:
- Srinivas Rao Naga Boyalapalli - Managing Director
- Devarakonda Ravi Sankar - Director
The latest financial statements of Rangsubbs Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Rangsubbs Pharmaceuticals (India) is 36AAICR4831M1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Rangsubbs Pharmaceuticals (India) is U24302TG2017PTC119103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rangsubbs Pharmaceuticals (India) was incorporated on 24 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Gangarapu Reddeppa Naidu ceased to be Additional Director on 26 Aug 2021. Devarakonda Ravi Sankar was appointed as Director on 16 Aug 2021. Devarakonda Ravi Sankar ceased to be Additional Director on 30 May 2020. Rangsubbs Pharmaceuticals (India) has 6 board changes on record in total.
Rangsubbs Pharmaceuticals (India) can be reached through the website rangsubbs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Rangsubbs Pharmaceuticals (India) is at Aparna Aura Apartments Flat No 906, Road No 79 Jubilee Hills, Hyderabad, Telangana, India – 500096.
Rangsubbs Pharmaceuticals (India) operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
